97
Views
19
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies

&
Pages 783-788 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Na Xu, Zhouqing Chen, Chongshun Zhao, Tao Xue, Xin Wu, Xiaoou Sun & Zhong Wang. (2018) Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials. Drug Design, Development and Therapy 12, pages 2071-2084.
Read now
Terence J Quinn & Jesse Dawson. (2009) Acute ‘strokenomics’: efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics & Outcomes Research 9:6, pages 513-522.
Read now

Articles from other publishers (17)

Adeel S. Zubair & Kevin N. Sheth. (2023) Hemorrhagic Conversion of Acute Ischemic Stroke. Neurotherapeutics 20:3, pages 705-711.
Crossref
D.V. Shchehlov, S.V. Konotopchyk & O.A. Pastushyn. (2022) Clinical protocol of the ischemic stroke patients treatment. Ukrainian Interventional Neuroradiology and Surgery 37:3, pages 14-56.
Crossref
Rong Ma, Qian Xie, Hongyan Li, Xiaoqing Guo, Jian Wang, Yong Li, Mihong Ren, Daoyin Gong & Tian Gao. (2021) l-Borneol Exerted the Neuroprotective Effect by Promoting Angiogenesis Coupled With Neurogenesis via Ang1-VEGF-BDNF Pathway. Frontiers in Pharmacology 12.
Crossref
Diji Kuriakose & Zhicheng Xiao. (2020) Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. International Journal of Molecular Sciences 21:20, pages 7609.
Crossref
Amarjot Kaur Grewal, Nirmal Singh & Thakur Gurjeet Singh. (2019) Neuroprotective effect of pharmacological postconditioning on cerebral ischaemia–reperfusion-induced injury in mice†. Journal of Pharmacy and Pharmacology 71:6, pages 956-970.
Crossref
Jin Liu, Qiuyan Shi, Yuan Sun, Jingyuan He, Bin Yang, Chunyang Zhang & Rui Guo. (2019) Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 28:4, pages 1126-1132.
Crossref
Manuel Zeitelhofer, Hong Li, Milena Z. Adzemovic, Ingrid Nilsson, Lars Muhl, Andrew M. Scott & Ulf Eriksson. (2018) Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice. PLOS ONE 13:7, pages e0200649.
Crossref
Mojdeh Nasiri & Mathew Reeves. 2016. Ischemic Stroke Therapeutics. Ischemic Stroke Therapeutics 295 307 .
Anjali Chauhan, Uma Sharma, Naranamangalam R. Jagannathan & Yogendra Kumar Gupta. (2015) Rapamycin ameliorates brain metabolites alterations after transient focal ischemia in rats. European Journal of Pharmacology 757, pages 28-33.
Crossref
Elio Clemente Agostoni & Marco Longoni. 2015. Arterial Disorders. Arterial Disorders 333 345 .
N.K. MishraN. AhmedA. DavalosH.K. IversenT. MeloL. SoinneN. WahlgrenK.R. Lees. (2011) Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology 77:21, pages 1866-1872.
Crossref
Nandavar Shobha, Rohit Bhatia, Matthew Boyko, Sarah Tymchuk, Gopukumar Kumarpillai, Eric Smith & Andrew M. Demchuk. (2011) Outcomes in Acute Ischemic Strokes Presenting with Disabling Neurologic Deficits without Intracranial Vascular Occlusion. International Journal of Stroke 6:5, pages 392-397.
Crossref
R. Brouns & P.P. De Deyn. (2009) The complexity of neurobiological processes in acute ischemic stroke. Clinical Neurology and Neurosurgery 111:6, pages 483-495.
Crossref
Joe Alcock & Andrew H. Brainard. (2008) Hemostatic containment – An evolutionary hypothesis of injury by innate immune cells. Medical Hypotheses 71:6, pages 960-968.
Crossref
K.R. Lees, G.A. Ford, K.W. Muir, N. Ahmed, A.G. Dyker, S. Atula, L. Kalra, E.A. Warburton, J.-C. Baron, D.F. Jenkinson, N.G. Wahlgren & M.R. Walters. (2008) Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM 101:11, pages 863-869.
Crossref
Peter Rieckmann. (2008) Imatinib buys time for brain after stroke. Nature Medicine 14:7, pages 712-713.
Crossref
M. Siebler, P.D. Schellinger, J. Sykora, H.J. Bäzne & M. Forsting. (2008) Update Thrombolyse des akuten ischämischen SchlaganfallsUpdate thrombolytic therapy in acute ischemic stroke. Notfall + Rettungsmedizin 11:3, pages 178-182.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.